The importance of BMPs and TGF-βs for endochondral bone repair – A longitudinal study in hip arthroplasty patients

IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM
Jean Cassuto , Agnetha Folestad , Jan Göthlin , Henrik Malchau , Johan Kärrholm
{"title":"The importance of BMPs and TGF-βs for endochondral bone repair – A longitudinal study in hip arthroplasty patients","authors":"Jean Cassuto ,&nbsp;Agnetha Folestad ,&nbsp;Jan Göthlin ,&nbsp;Henrik Malchau ,&nbsp;Johan Kärrholm","doi":"10.1016/j.bonr.2023.101723","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Osseointegration of hip implants, although a decade-long process, shows striking similarities with the four major phases of endochondral bone repair. In the current study we investigated the spatiotemporal involvement of bone morphogenic proteins (BMPs) and transforming growth factor betas (TGF-βs) throughout the process of bone repair leading to successfully osseointegrated hip implants.</p></div><div><h3>Materials and methods</h3><p>Twenty-four patients that had undergone primary total hip arthroplasty (THA) due to one-sided osteoarthritis (OA) were investigated during a period of 18 years (Y) with repeated measurements of plasma biomarkers as well as clinical and radiological variables. All implants were clinically and radiographically well anchored throughout the follow-up. Eighty-one healthy donors divided in three gender- and age-matched groups and twenty OA patients awaiting THA, served as controls. Plasma was analyzed for BMP-1, -2, -3, -4, -6, -7 -9 and TGF-β1, -β2, -β3 by use of a high-sensitivity and wide dynamic range electrochemiluminescence technique allowing for detection of minor changes.</p></div><div><h3>Results</h3><p>Spatiotemporal changes during the follow-up are presented in the context of the four phases of endochondral bone repair shown in earlier studies and transposed to the current study based on similarities in biomarker responses. Phase 1: <em>Primary proinflammatory phase</em> lasting from surgery until day 7, Phase 2: <em>Chondrogenic phase</em> from day 7 until 18 months postsurgery, Phase 3: <em>Secondary proinflammatory and cartilage remodeling phase</em> lasting from 18 months until 7Y, Phase 4: <em>coupled bone remodeling</em> from 7Y until 18Y postsurgery. BMP-1 increased sharply shortly after surgery and remained significantly above healthy during the chondrocyte recruitment, proliferation, and hypertrophy phases with a subsequent return to control level at 5Y postsurgery. BMP-2 was above healthy controls before surgery and 1 day after surgery before decreasing to control level and remaining there throughout the follow-up. BMP-3 was at control level from presurgery until 6M after surgery when it increased to a peak at 2Y during the cartilage hypertrophy phase followed by a gradual decrease to control level at 10Y during the phase of bone formation. In the following, BMP-3 decreased below controls to a nadir 15Y postsurgery during coupled bone remodeling. BMP-4 was at control level from presurgery until 10Y postsurgery when it increased to a sharp peak at 15Y after surgery followed by a return to the level of healthy at 18Y. BMP-6 did not differ from healthy during the follow-up. BMP-7 was at control level from presurgery until 1Y postsurgery before gradually increasing to a peak at 10Y during the early phase of osteogenesis with a gradual return to control level at 18Y during the phase of coupled bone remodeling. BMP-9 was above OA before surgery followed by a decrease to basal level on day 1 after surgery and a renewed increase to a plateau above controls lasting from 6 W until returning to the level of healthy at 18Y postsurgery, i.e., throughout the phases of cartilage formation, cartilage hypertrophy and remodeling, bone formation and coupled bone remodeling. TGF-β1 was above controls presurgery before decreasing to baseline shortly after surgery followed by a renewed increase at 6 M to a peak at 2Y during cartilage hypertrophy/remodeling followed by a gradual return to baseline at 10Y during early osteoblastogenesis. TGF-β2 was at control level from presurgery until the phase of cartilage remodeling at 5Y when it increased sharply to a peak at 7Y with a gradual return to baseline at 18Y postsurgery. TGF-β3 remained at control level throughout the study.</p></div><div><h3>Conclusion</h3><p>This study shows that the involvement of BMPs and TGF-βs in endochondral bone repair is a process of stepwise recruitment of individual biomarkers characterized by distinct, yet overlaping, spatiotemporal patterns that extend from the early phase of pre-chondrocyte recruitment until the late phase of coupled bone remodeling.</p></div>","PeriodicalId":9043,"journal":{"name":"Bone Reports","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2023-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2352187223000694/pdfft?md5=3c682b8d3d61fed52d8375815f726e3e&pid=1-s2.0-S2352187223000694-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352187223000694","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Osseointegration of hip implants, although a decade-long process, shows striking similarities with the four major phases of endochondral bone repair. In the current study we investigated the spatiotemporal involvement of bone morphogenic proteins (BMPs) and transforming growth factor betas (TGF-βs) throughout the process of bone repair leading to successfully osseointegrated hip implants.

Materials and methods

Twenty-four patients that had undergone primary total hip arthroplasty (THA) due to one-sided osteoarthritis (OA) were investigated during a period of 18 years (Y) with repeated measurements of plasma biomarkers as well as clinical and radiological variables. All implants were clinically and radiographically well anchored throughout the follow-up. Eighty-one healthy donors divided in three gender- and age-matched groups and twenty OA patients awaiting THA, served as controls. Plasma was analyzed for BMP-1, -2, -3, -4, -6, -7 -9 and TGF-β1, -β2, -β3 by use of a high-sensitivity and wide dynamic range electrochemiluminescence technique allowing for detection of minor changes.

Results

Spatiotemporal changes during the follow-up are presented in the context of the four phases of endochondral bone repair shown in earlier studies and transposed to the current study based on similarities in biomarker responses. Phase 1: Primary proinflammatory phase lasting from surgery until day 7, Phase 2: Chondrogenic phase from day 7 until 18 months postsurgery, Phase 3: Secondary proinflammatory and cartilage remodeling phase lasting from 18 months until 7Y, Phase 4: coupled bone remodeling from 7Y until 18Y postsurgery. BMP-1 increased sharply shortly after surgery and remained significantly above healthy during the chondrocyte recruitment, proliferation, and hypertrophy phases with a subsequent return to control level at 5Y postsurgery. BMP-2 was above healthy controls before surgery and 1 day after surgery before decreasing to control level and remaining there throughout the follow-up. BMP-3 was at control level from presurgery until 6M after surgery when it increased to a peak at 2Y during the cartilage hypertrophy phase followed by a gradual decrease to control level at 10Y during the phase of bone formation. In the following, BMP-3 decreased below controls to a nadir 15Y postsurgery during coupled bone remodeling. BMP-4 was at control level from presurgery until 10Y postsurgery when it increased to a sharp peak at 15Y after surgery followed by a return to the level of healthy at 18Y. BMP-6 did not differ from healthy during the follow-up. BMP-7 was at control level from presurgery until 1Y postsurgery before gradually increasing to a peak at 10Y during the early phase of osteogenesis with a gradual return to control level at 18Y during the phase of coupled bone remodeling. BMP-9 was above OA before surgery followed by a decrease to basal level on day 1 after surgery and a renewed increase to a plateau above controls lasting from 6 W until returning to the level of healthy at 18Y postsurgery, i.e., throughout the phases of cartilage formation, cartilage hypertrophy and remodeling, bone formation and coupled bone remodeling. TGF-β1 was above controls presurgery before decreasing to baseline shortly after surgery followed by a renewed increase at 6 M to a peak at 2Y during cartilage hypertrophy/remodeling followed by a gradual return to baseline at 10Y during early osteoblastogenesis. TGF-β2 was at control level from presurgery until the phase of cartilage remodeling at 5Y when it increased sharply to a peak at 7Y with a gradual return to baseline at 18Y postsurgery. TGF-β3 remained at control level throughout the study.

Conclusion

This study shows that the involvement of BMPs and TGF-βs in endochondral bone repair is a process of stepwise recruitment of individual biomarkers characterized by distinct, yet overlaping, spatiotemporal patterns that extend from the early phase of pre-chondrocyte recruitment until the late phase of coupled bone remodeling.

bmp和TGF-βs在软骨内骨修复中的重要性——一项髋关节置换术患者的纵向研究
髋关节骨整合虽然是一个长达十年的过程,但与软骨内骨修复的四个主要阶段有着惊人的相似之处。在目前的研究中,我们研究了骨形态发生蛋白(BMPs)和转化生长因子β (TGF-βs)在骨修复过程中的时空参与,导致骨整合髋关节植入物的成功。材料和方法对24例因单侧骨关节炎(OA)接受原发性全髋关节置换术(THA)的患者进行了为期18年(Y)的研究,反复测量血浆生物标志物以及临床和放射学变量。在随访期间,所有种植体均在临床和影像学上锚定良好。81名健康供体分为三个性别和年龄匹配的组,20名等待THA的OA患者作为对照。采用高灵敏度、宽动态范围的电化学发光技术检测血浆中BMP-1、-2、-3、-4、-6、-7 -9和TGF-β1、-β2、-β3。结果:随访期间的时空变化是在早期研究中显示的软骨内骨修复的四个阶段的背景下呈现的,并基于生物标志物反应的相似性转置到当前的研究中。第1阶段:原发性促炎期,从手术持续到第7天;第2阶段:软骨形成期,从手术后第7天到18个月;第3阶段:继发性促炎和软骨重塑期,从18个月持续到7岁;第4阶段:从7岁到18岁的骨重塑。术后不久BMP-1急剧升高,并在软骨细胞募集、增殖和肥大期保持明显高于健康水平,随后在术后5Y时恢复到控制水平。术前和术后1天BMP-2均高于健康对照组,随后降至控制水平,并在随访期间保持该水平。BMP-3从术前到术后6M处于控制水平,在软骨肥厚期2Y时达到峰值,在成骨期10Y时逐渐下降至控制水平。在接下来的研究中,在骨重建过程中,BMP-3比对照组下降到15Y的最低点。从术前到术后10Y, BMP-4均处于控制水平,术后15Y时达到高峰,18Y时恢复健康水平。在随访期间,BMP-6与健康无差异。从术前到术后1Y, BMP-7处于控制水平,在成骨早期10Y时逐渐升高至峰值,在耦合骨重塑阶段18Y时逐渐恢复到控制水平。术前BMP-9高于OA,术后第1天降至基础水平,术后6 W再次上升至高于对照组的平台,直到术后18Y恢复到健康水平,即贯穿软骨形成、软骨肥大和重塑、骨形成和骨重建的整个阶段。TGF-β1在手术前高于对照组,术后不久降至基线,在6 M时再次升高,在软骨肥大/重塑期间2Y时达到峰值,随后在早期成骨发生期间10Y时逐渐恢复到基线。TGF-β2从术前至5Y软骨重塑期均处于对照水平,在7Y时急剧升高至峰值,术后18Y时逐渐恢复到基线水平。TGF-β3在整个研究过程中保持在对照水平。本研究表明,bmp和TGF-βs参与软骨内骨修复是一个个体生物标志物的逐步募集过程,其特征具有不同但重叠的时空模式,从早期的软骨前细胞募集到晚期的偶联骨重塑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bone Reports
Bone Reports Medicine-Orthopedics and Sports Medicine
CiteScore
4.30
自引率
4.00%
发文量
444
审稿时长
57 days
期刊介绍: Bone Reports is an interdisciplinary forum for the rapid publication of Original Research Articles and Case Reports across basic, translational and clinical aspects of bone and mineral metabolism. The journal publishes papers that are scientifically sound, with the peer review process focused principally on verifying sound methodologies, and correct data analysis and interpretation. We welcome studies either replicating or failing to replicate a previous study, and null findings. We fulfil a critical and current need to enhance research by publishing reproducibility studies and null findings.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信